Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.

Fourteen patients with severe viral illnesses were given intravenous infusions of a modified interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine complexed with carboxymethylcellulose [poly)I:C.LC)], during a phase 1 clinical trial. The first eight patients received 0.15 to 0.30...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Infect Immun
Autori principali:	Champney, K J, Levine, D P, Levy, H B, Lerner, A M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1979
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC414523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/500189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.25.3.831-837.1979
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!